Radiopharm Theranostics Limited (ASX:RAD)

Radiopharm Theranostics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	36.44	18.58	11.7	26.98	0.03
Cash & Short-Term Investments	36.44	18.58	11.7	26.98	0.03
Cash Growth	1823.88%	58.77%	-56.64%	99486.97%	-
Accounts Receivable	4.63	-	0.1	0.06	-
Other Receivables	1.62	0.99	4.36	0	0.01
Receivables	6.25	0.99	4.47	0.06	0.01
Other Current Assets	-	3.29	0.13	0.23	-
Total Current Assets	44.35	22.85	16.3	27.26	0.03
Property, Plant & Equipment	0.06	0.06	0.07	0	-
Other Intangible Assets	48	49.09	58.54	56.08	-
Other Long-Term Assets	0.04	0.04	0.04	0.04	-
Total Assets	92.45	72.04	74.95	83.38	0.03
Accounts Payable	3.14	6.43	2.96	1.19	0.06
Accrued Expenses	4.59	2.57	2.11	1.02	0.03
Short-Term Debt	-	-	-	-	0.06
Other Current Liabilities	2.26	8.57	8.16	5.66	-
Total Current Liabilities	13.15	17.58	13.23	7.88	0.16
Other Long-Term Liabilities	27.3	27.11	16.14	12.54	-
Total Liabilities	40.45	44.68	29.37	20.42	0.16
Common Stock	168.28	100.68	97.23	86.76	0
Retained Earnings	-127.79	-111.34	-65.35	-30.91	-0.49
Comprehensive Income & Other	12.71	38.78	12.51	7.11	0.36
Total Common Equity	53.2	28.12	44.38	62.96	-0.12
Minority Interest	-1.2	-0.77	1.19	-	-
Shareholders' Equity	52	27.35	45.58	62.96	-0.12
Total Liabilities & Equity	92.45	72.04	74.95	83.38	0.03
Total Debt	-	-	-	-	0.06
Net Cash (Debt)	36.44	18.58	11.7	26.98	-0.03
Net Cash Growth	1823.88%	58.77%	-56.64%	-	-
Net Cash Per Share	0.03	0.05	0.04	0.15	-
Filing Date Shares Outstanding	2,201	2,173	339.31	255.43	100
Total Common Shares Outstanding	2,201	460.37	339.31	255.43	100
Working Capital	31.21	5.27	3.07	19.39	-0.12
Book Value Per Share	0.02	0.06	0.13	0.25	-0.00
Tangible Book Value	5.2	-20.96	-14.16	6.89	-0.12
Tangible Book Value Per Share	0.00	-0.05	-0.04	0.03	-0.00

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.